Brown, Christine E.

Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity

Wang, D., Aguilar, B., Starr, R., Alizadeh, D., Brito, A., Sarkissian, A., Ostberg, J. R., Forman, S. J., & Brown, C. E. (2018) · JCI Insight

CAR-T cell therapy researchGlioma Diagnosis and Treatment

Cited by 233

Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma

Zah, E., Nam, E., Bhuvan, V., Tran, U., Ji, B. Y., Gosliner, S. B., Wang, X., Brown, C. E., & Chen, Y. Y. (2020) · Nature Communications

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 222

Transcription Activator Interactions with Multiple SWI/SNF Subunits

Neely, K. E., Hassan, A. H., Brown, C. E., Howe, L., & Workman, J. L. (2002) · Molecular and Cellular Biology

Chromatin Remodeling and CancerGenomics and Chromatin Dynamics

Cited by 183

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Simonds, E. F., Lu, E. D., Badillo, O., Karimi, S., Liu, E. V., Tamaki, W., Rancan, C., Downey, K. M., Stultz, J., Sinha, M., et al. (2021) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersGlioma Diagnosis and Treatment

Cited by 119

Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy

Chen, S., Lai, S. W. T., Brown, C. E., & Feng, M. (2021) · Frontiers in Immunology

Immune cells in cancerPhagocytosis and Immune Regulation

Cited by 91